Back
63
31
Also listed as
ESALF
OTC
Day Range
$7.54
$7.64
52-Week Range
$5.94
$9.22
Volume
4,900
50D / 200D Avg
$7.56
/
$7.52
Prev Close
$7.52
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.2 | 0.3 |
| P/B | 0.0 | 3.0 |
| ROE % | 5.4 | 3.7 |
| Net Margin % | 5.9 | 3.8 |
| Rev Growth 5Y % | 5.1 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$39.14
$37.47 – $40.69
|
865.73B | 1 |
| FY2026 |
$40.70
$38.97 – $42.31
|
857.90B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | $0.10 | — |
| 2025-11-06 | N/A | $0.06 | — |
| 2025-08-04 | N/A | $0.09 | — |
| 2025-05-13 | N/A | $0.01 | — |
| 2025-02-04 | N/A | $0.00 | — |
| 2024-08-02 | N/A | $0.06 | — |
| 2024-05-15 | N/A | $0.08 | — |
| 2024-03-07 | N/A | $0.04 | — |
Dividend History
Yield
0.04%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Sep 30, 2025 | — | $0.10 | 2.82% |
| Mar 31, 2025 | — | $0.14 | 3.88% |
| Sep 30, 2024 | — | $0.13 | 2.78% |
| Mar 27, 2024 | — | $0.13 | 2.50% |
| Sep 28, 2023 | — | $0.13 | 1.99% |
| Mar 30, 2023 | — | $0.14 | 1.02% |
| Mar 27, 2019 | May 30, 2019 | $0.72 | 8.66% |
| Sep 26, 2018 | Nov 27, 2018 | $0.62 | 8.72% |
| Mar 28, 2018 | Jun 01, 2018 | $0.73 | 8.73% |
| Sep 27, 2017 | Nov 27, 2017 | $0.62 | 8.63% |
| Mar 29, 2017 | May 26, 2017 | $0.72 | 8.68% |
| Sep 28, 2016 | Nov 28, 2016 | $0.63 | 8.77% |
| Mar 29, 2016 | May 31, 2016 | $0.73 | 8.35% |
| Sep 28, 2015 | Nov 25, 2015 | $0.57 | 7.88% |
| Mar 29, 2015 | Jun 01, 2015 | $0.66 | 8.11% |
| Sep 28, 2014 | Nov 24, 2014 | $0.60 | 8.93% |
| Mar 27, 2014 | May 30, 2014 | $0.79 | 9.56% |
| Sep 26, 2013 | Nov 22, 2013 | $0.70 | 9.50% |
| Mar 27, 2013 | May 30, 2013 | $0.78 | 10.54% |
| Sep 26, 2012 | Nov 26, 2012 | $0.86 | 12.02% |
Key Takeaways
Revenue grew 5.14% annually over 5 years — modest growth
Debt/Equity of 0.22 — conservative balance sheet
Generating 7.15B in free cash flow
P/E of 0.19 — trading at a low valuation
Capital efficient — spends only 2.91% of revenue on capex
ROIC of 3.96% — low return on invested capital
Growth
Revenue Growth (5Y)
5.14%
Revenue (1Y)6.42%
Earnings (1Y)9.49%
FCF Growth (3Y)N/A
Quality
Return on Equity
5.41%
ROIC3.96%
Net Margin5.88%
Op. Margin6.89%
Safety
Debt / Equity
0.22
Current Ratio1.95
Interest Coverage15.45
Valuation
P/E Ratio
0.19
Forward P/EN/A
P/B Ratio0.01
EV/EBITDA-1.28
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.42% | Revenue Growth (3Y) | 2.98% |
| Earnings Growth (1Y) | 9.49% | Earnings Growth (3Y) | -8.48% |
| Revenue Growth (5Y) | 5.14% | Earnings Growth (5Y) | 2.58% |
| Profitability | |||
| Revenue (TTM) | 789.40B | Net Income (TTM) | 46.43B |
| ROE | 5.41% | ROA | 3.35% |
| Gross Margin | 78.62% | Operating Margin | 6.89% |
| Net Margin | 5.88% | Free Cash Flow (TTM) | 7.15B |
| ROIC | 3.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 1.95 |
| Interest Coverage | 15.45 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.19 | Forward P/E | N/A |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | 2.36 | Forward PEG | N/A |
| EV/EBITDA | -1.28 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 82.58% | ||
| Market Cap | 8.66B | Enterprise Value | -69.38B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 789.40B | 741.75B | 744.40B | 756.23B | 645.94B |
| Net Income | 46.43B | 42.41B | 55.43B | 47.95B | 41.94B |
| EPS (Diluted) | 40.94 | 36.97 | 48.33 | 41.81 | 36.73 |
| Gross Profit | 620.59B | 586.42B | 566.57B | 581.40B | 484.63B |
| Operating Income | 54.38B | 53.41B | 40.04B | 53.75B | 53.22B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.39T | 1.39T | 1.26T | 1.24T | 1.09T |
| Total Liabilities | 520.58B | 494.82B | 440.78B | 467.78B | 362.07B |
| Shareholders' Equity | 841.42B | 875.61B | 799.96B | 748.82B | 703.18B |
| Total Debt | 187.52B | 159.41B | 126.11B | 94.89B | 89.89B |
| Cash & Equivalents | 265.56B | 304.68B | 267.35B | 309.63B | 248.74B |
| Current Assets | 727.66B | 722.98B | 622.20B | 640.61B | 518.34B |
| Current Liabilities | 372.29B | 304.47B | 298.95B | 313.33B | 256.02B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#105 of 827
#314 of 709
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026